• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NasdaqGM
    12.13 Up 2.00(19.74%) Feb 5, 4:00PM EST
    |After Hours : 12.14 Up 0.01 (0.08%) Feb 5, 7:28PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 122,045   12,019   1,480  
    Cost of Revenue5,758  1,104   -  
    Gross Profit 116,287   10,915   1,480  
    Operating Expenses
    Research Development19,586  17,245  23,517  
    Selling General and Administrative72,471  55,590  20,132  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 24,230   (61,920) (42,169)
    Income from Continuing Operations
    Total Other Income/Expenses Net604  (22,504)(540)
    Earnings Before Interest And Taxes27,426  (74,874)(42,709)
    Interest Expense4,963  7,849  3,575  
    Income Before Tax22,463  (82,723)(46,284)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops19,871  (92,273)(46,284)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 19,871   (92,273) (46,284)
    Preferred Stock And Other Adjustments -   -  (1,143)
    Net Income Applicable To Common Shares 19,871   (92,273) (47,427)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.